Sermorelin, GHRP-6, GHRP-2 9mg (Blend)
$95.00
The Sermorelin, GHRP-6, and GHRP-2 9mg Blend is a precision-engineered triple-peptide combination designed for advanced somatotropic axis research, supplied at ≥98% purity as a sterile lyophilized matrix. By aligning a structural GHRH analog with two distinct ghrelin receptor agonists, this blend enables investigators to study multi-channel pituitary signaling pathways under controlled laboratory conditions. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
The Sermorelin, GHRP-6, and GHRP-2 9mg Blend is a precision-engineered triple-peptide combination formulated for advanced somatotropic axis research. Supplied at ≥98% purity and presented as a sterile lyophilized matrix, this blend enables investigators to study multi-channel pituitary signaling through simultaneous GHRH analog and ghrelin receptor agonist activity. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
Product Overview
Available exclusively at The Peptide Store, the Sermorelin, GHRP-6, and GHRP-2 9mg Blend represents a sophisticated multi-valent approach to neuroendocrine research. This three-component formulation is designed to model concurrent receptor saturation across distinct pituitary signaling pathways, making it one of the most comprehensive secretagogue research tools currently available for sale online. Researchers investigating growth hormone axis dynamics, hypothalamic–pituitary feedback loops, or comparative secretagogue pharmacology will find this blend an exceptional addition to their laboratory toolkit.
Peptide Structure & Amino Acid Sequence
This blend integrates three structurally distinct peptide entities, each contributing a unique receptor-binding profile:
- Sermorelin – A 29-amino acid synthetic analog corresponding to the biologically active N-terminal fragment of endogenous Growth Hormone Releasing Hormone (GHRH 1-29). Its sequence initiates GHRH receptor (GHRHR) engagement on somatotroph cells.
- GHRP-6 (Growth Hormone Releasing Peptide-6) – A hexapeptide secretagogue (His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂) that acts as a ghrelin receptor (GHS-R1a) agonist, amplifying pulsatile growth hormone release through a mechanism distinct from GHRH signaling.
- GHRP-2 (Growth Hormone Releasing Peptide-2) – A second-generation hexapeptide secretagogue with higher GHS-R1a binding affinity than GHRP-6, offering researchers a comparative model of differential receptor potency within the same experimental system.
The co-presence of these three peptides within a single lyophilized matrix allows for simultaneous multi-pathway receptor engagement studies under controlled in vitro or ex vivo laboratory conditions.
Chemical & Physical Characteristics
- Composition: Sermorelin, GHRP-6, GHRP-2 (triple-peptide blend)
- Presentation: Sterile lyophilized powder
- Purity: ≥98% (per component, verified by HPLC)
- Molecular Weight: Variable per component; combined formulation engineered for balanced receptor-binding stoichiometry
- Appearance: White to off-white lyophilized cake or powder
- Solubility: Soluble in aqueous buffers suitable for in vitro laboratory applications
Purity & Analytical Verification (HPLC & MS)
Each batch of the Sermorelin, GHRP-6, and GHRP-2 9mg Blend produced for The Peptide Store undergoes rigorous analytical verification prior to release. High-Performance Liquid Chromatography (HPLC) is used to confirm that each individual peptide component achieves ≥98% purity, while Mass Spectrometry (MS) validates the molecular identity and integrity of all three peptides within the blend. Certificate of Analysis (CoA) data is available upon request, ensuring full traceability and batch-level quality assurance for research procurement teams.
Quality Control & Lyophilization Integrity
Lyophilization (freeze-drying) is employed to stabilize this complex multi-peptide formulation against degradation during transport and storage. The lyophilization process removes residual moisture to levels that preserve peptide secondary structure and biological activity relevant to research applications. Each vial is sealed under inert conditions to prevent oxidative degradation, and quality control protocols include visual inspection, moisture content verification, and reconstitution behavior assessment prior to dispatch.
Safety, Handling & Laboratory Precautions
This product is intended exclusively for qualified researchers operating within properly equipped laboratory environments. Standard laboratory personal protective equipment (PPE) — including gloves, eye protection, and appropriate lab coats — should be worn when handling lyophilized peptide material. Avoid inhalation of powder. All handling, storage, and disposal must comply with applicable institutional biosafety guidelines and local regulatory requirements. This product is not approved for any use outside of controlled research settings.
Reconstitution, Packaging & Storage
The Sermorelin, GHRP-6, and GHRP-2 9mg Blend is packaged in sealed, laboratory-grade vials suitable for research-scale use. For long-term preservation, store lyophilized material at −20°C in a dry, dark environment away from direct light and humidity. Once reconstituted using a research-appropriate aqueous solvent under sterile laboratory conditions, the solution should be aliquoted and stored at 4°C for short-term use. Repeated freeze-thaw cycles should be avoided to maintain peptide integrity. Reconstitution protocols should be determined by the principal investigator based on the specific experimental design.
Intended Research Use & Market Positioning
The Sermorelin, GHRP-6, and GHRP-2 9mg Blend is positioned as a premium-grade research tool for investigators studying hypothalamic–pituitary axis signaling, comparative secretagogue receptor pharmacology, and multi-pathway growth hormone regulatory mechanisms. Its triple-component architecture makes it uniquely suited for experimental designs requiring simultaneous GHRH receptor and GHS-R1a engagement. Buy this research peptide blend online from The Peptide Store for competitive pricing, verified purity, and reliable fulfillment.
Ordering, Availability & Fulfillment
The Peptide Store offers the Sermorelin, GHRP-6, and GHRP-2 9mg Blend for sale online with straightforward ordering, fast dispatch, and discreet laboratory-grade packaging. Our inventory is maintained to ensure consistent availability for ongoing research programs. Order now to take advantage of our best price guarantee, and benefit from our dedicated customer support team available to assist research procurement professionals. Bulk and institutional orders are welcomed — contact us directly for volume pricing inquiries.
Legal & Regulatory Disclaimer
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. The Sermorelin, GHRP-6, and GHRP-2 9mg Blend is sold exclusively as a laboratory research reagent. It has not been evaluated or approved by any regulatory authority for therapeutic, prophylactic, or diagnostic use in humans or animals. Purchasers are solely responsible for ensuring that acquisition, possession, and use of this product comply with all applicable local, national, and international laws and regulations. The Peptide Store assumes no liability for misuse, unauthorized application, or regulatory non-compliance by the purchaser.
Related products
CJC-1295 (no DAC), Hexarelin 10mg (Blend)
PRODUCT SHORT DESCRIPTION
The CJC-1295 No DAC and Hexarelin formulation delivers an advanced, dual-action 10mg (10000mcg) research blend combining two synergistic synthetic peptides in a single vial. This ratio is engineered strictly for investigating dual-receptor somatotroph coordination, optimized growth hormone (GH) pulsatility curves, and growth hormone secretagogue receptor mechanics.
CJC-1295 (No DAC), Ipamorelin, GHRP-2 (Blend)
PRODUCT SHORT DESCRIPTION
The CJC-1295 No DAC, Ipamorelin, and GHRP-2 formulation delivers an advanced, triple-action research blend combining three synergistic synthetic peptides in a single vial. This ratio is engineered strictly for investigating dual-receptor somatotroph coordination, optimized growth hormone (GH) pulsatility curves, and distinct growth hormone secretagogue receptor signaling mechanics.
CJC-1295 No DAC (Modified GRF 1-29)+ Ipamorelin 10mg Blend
CJC-1295 No DAC Ipamorelin 10mg Blend 5mg CJC-1295 No DAC (Modified GRF 1-29) + 5mg Ipamorelin per vial. Lyophilised powder, dual-compound. ≥99% purity by HPLC. Third-party tested Janoshik Analytical. Heavy metals & endotoxin screened. COA verified per batch. USA-manufactured. $95.00 In stock. For laboratory research use only.
Fragment, Modified GRF, Ipamorelin 12mg (Blend)
PRODUCT SHORT DESCRIPTION
The Fragment, Modified GRF, and Ipamorelin formulation delivers an advanced, triple-action 12mg (12000mcg) research blend combining three synergistic synthetic peptides in a single vial. This ratio is engineered strictly for investigating dual-receptor somatotroph coordination, optimized growth hormone (GH) pulsatility, and parallel lipid metabolism pathways.
GHRP-2 10mg
PRODUCT SHORT DESCRIPTION
GHRP-2 5mg is a premium, high-purity synthetic hexapeptide engineered for advanced endocrine and metabolic axis evaluation. This 5000mcg formulation provides a highly potent biochemical tool for investigating GHS-R1a receptor kinetics, secondary messenger signaling cascades, and pulsatile growth hormone (GH) transcription.
Hexarelin 2mg
PRODUCT SHORT DESCRIPTION
Hexarelin 2mg is a premium, high-purity synthetic hexapeptide engineered for advanced endocrine and cardiovascular axis evaluation. This 2000mcg formulation provides a highly potent biochemical tool for investigating GHS-R1a receptor kinetics, structural cardiac cell preservation, and maximum growth hormone (GH) pulsatility.
IGF-1 DES 1mg
PRODUCT SHORT DESCRIPTION
IGF-1 DES 1mg is a premium, high-purity synthetic 67-amino-acid truncated variant of Insulin-like Growth Factor-1. This 1000mcg configuration provides an isolated biochemical tool for investigating localized receptor binding kinetics, rapid hypertrophy pathways, and cellular repair mechanics under conditions of altered binding protein availability.
Ipamorelin (5mg x 10), CJC-1295 no DAC (5mg x 10)
PRODUCT SHORT DESCRIPTION
The Ipamorelin and CJC-1295 No DAC combination platform delivers a high-resolution, multi-vial research kit containing ten 5mg vials of Ipamorelin alongside ten 5mg vials of CJC-1295 No DAC. This 5000mcg per vial configuration is engineered strictly for investigating dual-receptor somatotroph coordination, amplified growth hormone (GH) pulsatility, and downstream endocrine signaling kinetics.

Reviews
There are no reviews yet.